Literature DB >> 27733244

Tuberculosis-diabetes epidemiology in the border and non-border regions of Tamaulipas, Mexico.

Bassent E Abdelbary1, Moncerrato Garcia-Viveros2, Horacio Ramirez-Oropesa2, Mohammad H Rahbar3, Blanca I Restrepo4.   

Abstract

Type 2 diabetes mellitus (DM) is a re-emerging risk factor for TB development and adverse TB outcomes. As a follow-up of our previous study in 1998-2004, we reassessed prevalence of DM and its associated factors among 8431 TB patients using surveillance data from 2006 to 2013 for the Mexican state of Tamaulipas, across the border with Texas. Prevalence of DM was 25.2%, with an increase of at least 2.8% over the study period. Newly discovered factors associated with TB-DM (versus no DM) were lower education and higher unemployment (p < 0.001), which are reportedly associated with poorer DM management. At least 15% of the DM patients were newly-diagnosed and younger than those previously diagnosed, showing the importance of early DM diagnosis at TB clinics. TB-DM patients were more likely to have smear-positive, pulmonary (versus extra-pulmonary) and drug-resistant TB (1.9-, 3.8- and 1.4-fold, respectively). During treatment, TB-DM patients were more likely to be smear-positive, and less likely to die or abandon TB treatment. Thus, the increasing prevalence of DM among TB, and its association with low education, features of a more contagious TB, and drug resistance, highlight the need for design of TB management programs in DM patients, blood testing of all new TB patients for DM, and if positive for DM, testing for drug resistance.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Border; Diabetes; Epidemiology; Mexico; Tamaulipas; Texas; Tuberculosis

Mesh:

Substances:

Year:  2016        PMID: 27733244     DOI: 10.1016/j.tube.2016.09.024

Source DB:  PubMed          Journal:  Tuberculosis (Edinb)        ISSN: 1472-9792            Impact factor:   3.131


  10 in total

Review 1.  Diabetes and Tuberculosis.

Authors:  Blanca I Restrepo
Journal:  Microbiol Spectr       Date:  2016-12

Review 2.  Stress Hyperglycemia in Patients with Tuberculosis Disease: Epidemiology and Clinical Implications.

Authors:  Matthew J Magee; Argita D Salindri; Nang Thu Thu Kyaw; Sara C Auld; J Sonya Haw; Guillermo E Umpierrez
Journal:  Curr Diab Rep       Date:  2018-08-09       Impact factor: 4.810

3.  Lipid mediators of inflammation and Resolution in individuals with tuberculosis and tuberculosis-Diabetes.

Authors:  Rupak Shivakoti; Jesmond Dalli; Dileep Kadam; Sanjay Gaikwad; Madhusudan Barthwal; Romain A Colas; Francesca Mazzacuva; Rahul Lokhande; Sujata Dharmshale; Renu Bharadwaj; Anju Kagal; Neeta Pradhan; Sona Deshmukh; Sachin Atre; Tushar Sahasrabudhe; Arjun Kakrani; Vandana Kulkarni; Swapnil Raskar; Nishi Suryavanshi; Sandy Chon; Akshay Gupte; Amita Gupta; Nikhil Gupte; María B Arriaga; Kiyoshi F Fukutani; Bruno B Andrade; Jonathan E Golub; Vidya Mave
Journal:  Prostaglandins Other Lipid Mediat       Date:  2019-11-11       Impact factor: 3.072

Review 4.  Defining a Research Agenda to Address the Converging Epidemics of Tuberculosis and Diabetes: Part 2: Underlying Biologic Mechanisms.

Authors:  Katharina Ronacher; Reinout van Crevel; Julia A Critchley; Andrew A Bremer; Larry S Schlesinger; Anil Kapur; Randall Basaraba; Hardy Kornfeld; Blanca I Restrepo
Journal:  Chest       Date:  2017-04-20       Impact factor: 9.410

Review 5.  Defining a Research Agenda to Address the Converging Epidemics of Tuberculosis and Diabetes: Part 1: Epidemiology and Clinical Management.

Authors:  Julia A Critchley; Blanca I Restrepo; Katharina Ronacher; Anil Kapur; Andrew A Bremer; Larry S Schlesinger; Randall Basaraba; Hardy Kornfeld; Reinout van Crevel
Journal:  Chest       Date:  2017-04-20       Impact factor: 9.410

6.  Predicting treatment failure, death and drug resistance using a computed risk score among newly diagnosed TB patients in Tamaulipas, Mexico.

Authors:  B E Abdelbary; M Garcia-Viveros; H Ramirez-Oropesa; M H Rahbar; B I Restrepo
Journal:  Epidemiol Infect       Date:  2017-09-14       Impact factor: 4.434

7.  Association of Body Mass Index with the Tuberculosis Infection: a Population-based Study among 17796 Adults in Rural China.

Authors:  Haoran Zhang; Xiangwei Li; Henan Xin; Hengjing Li; Mufei Li; Wei Lu; Liqiong Bai; Xinhua Wang; Jianmin Liu; Qi Jin; Lei Gao
Journal:  Sci Rep       Date:  2017-02-08       Impact factor: 4.379

8.  Diabetes, undernutrition, migration and indigenous communities: tuberculosis in Chiapas, Mexico.

Authors:  H A Rashak; H J Sánchez-Pérez; B E Abdelbary; A Bencomo-Alerm; N Enriquez-Ríos; A Gómez-Velasco; A Colorado; M Castellanos-Joya; M H Rahbar; B I Restrepo
Journal:  Epidemiol Infect       Date:  2019-01       Impact factor: 2.451

9.  Prevalence and Clinical Profiling of Dysglycemia and HIV Infection in Persons With Pulmonary Tuberculosis in Brazil.

Authors:  María B Arriaga; Mariana Araújo-Pereira; Beatriz Barreto-Duarte; Caio Sales; João Pedro Miguez-Pinto; Evelyn B Nogueira; Betânia M F Nogueira; Michael S Rocha; Alexandra B Souza; Aline Benjamin; Jamile G de Oliveira; Adriana S R Moreira; Artur T L Queiroz; Moreno M S Rodrigues; Renata Spener-Gomes; Marina C Figueiredo; Betina Durovni; Solange Cavalcante; José R Lapa-E-Silva; Afrânio L Kristki; Marcelo Cordeiro-Santos; Timothy R Sterling; Valeria C Rolla; Bruno B Andrade
Journal:  Front Med (Lausanne)       Date:  2022-01-21

10.  Determinants of delayed tuberculosis treatment among patients in Selangor: A study protocol.

Authors:  Punitha Makeswaran; Shamsul Azhar Shah; Nazarudin Safian; Nor Asiah Muhamad; Abdul Aziz Harith
Journal:  PLoS One       Date:  2022-04-25       Impact factor: 3.752

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.